Epizyme, Inc.
METHOD FOR TREATING CANCER
Last updated:
Abstract:
The present disclosure relates to pharmaceutical compositions comprising inhibitor(s) of human histone methyltransferase EZH2, and methods of cancer therapy using the EZH2 inhibitor(s).
Status:
Application
Type:
Utility
Filling date:
21 Dec 2020
Issue date:
15 Jul 2021